SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 348 filers reported holding SEATTLE GENETICS INC in Q1 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $803,000 | +125.6% | 9,397 | +82.6% | 0.02% | +137.5% |
| Q2 2019 | $356,000 | +50.2% | 5,147 | +59.3% | 0.01% | +60.0% |
| Q1 2019 | $237,000 | -90.7% | 3,232 | -90.1% | 0.01% | -90.6% |
| Q3 2018 | $2,562,000 | +242.1% | 32,714 | +189.8% | 0.05% | +278.6% |
| Q2 2018 | $749,000 | -33.1% | 11,290 | -47.2% | 0.01% | -41.7% |
| Q1 2018 | $1,120,000 | -43.5% | 21,398 | -41.9% | 0.02% | -44.2% |
| Q4 2017 | $1,984,000 | +9.7% | 36,823 | +5.4% | 0.04% | +19.4% |
| Q2 2017 | $1,808,000 | -57.9% | 34,943 | -57.1% | 0.04% | -76.5% |
| Q4 2016 | $4,295,000 | +16.8% | 81,393 | +19.6% | 0.15% | +34.2% |
| Q3 2016 | $3,676,000 | – | 68,068 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |